Analyst stock forecast
Nautilus Biotechnology Forecast: $4.00 Analyst Target
NAUT has a $4.00 target, none rating and 1 analysts. As of 2026-08-18.
Direct answer
Nautilus Biotechnology's average price target is $4.00.
The target implies +354.3% from the recorded current price, and the consensus rating is none.
The low target implies +354.3%, the high target implies +354.3%, and the range spans 0% of the current price.
Forecast evidence checked August 18, 2026.
Get free Nautilus Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.88
- Average price target
- $4.00
- High price target
- $4.00
- Low price target
- $4.00
- Low target gap
- +354.3%
- Target upside
- +354.3%
- High target gap
- +354.3%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is Nautilus Biotechnology's average price target?
Nautilus Biotechnology's verified average price target is $4.00. The target range is $4.00 to $4.00.
How far are Nautilus Biotechnology's low and high targets from the recorded price?
The low target implies +354.3%, while the high target implies +354.3%.
How many analysts are included in Nautilus Biotechnology's consensus?
The verified consensus includes 1 analysts.
How is Nautilus Biotechnology's target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $0.88, then one is subtracted to produce +354.3%. This does not guarantee a future return.
When was Nautilus Biotechnology's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.